ArticleCancer medicine2026
RETRACTION: miR-107 Regulates Growth and Metastasis of Gastric Cancer Cells via Activation of the PI3K-AKT Signaling Pathway by Down-Regulating FAT4.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionL. Wang, K. Li, C. Wang, X. Shi, and H. Yang, "miR-107 Regulates Growth and Metastasis of Gastric Cancer Cells via Activation of the PI3K-AKT Signaling Pathway by Down-Regulating FAT4," Cancer Medicine 8, no. 11 (2019): 5264-5273, https://doi.org/10.1002/cam4.2396. The above article, published online on 12 July 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by the journal Editor-in-Chief, Stephen Tait; and John Wiley & Sons Ltd. Concerns were raised by third parties regarding several areas of overlap in Figures 3A and 3B; duplications in Figure 4; and irregularities with the blots in Figures 1C, 5AB, and 6AB. The authors were unable to provide satisfactory explanations or original data to resolve these concerns. These issues undermine the reliability of the data and the conclusions drawn from the study. The authors have been informed about the retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.